J Pharmacol Exp Ther 282(3):15331540 Thompson RA, Isin EM, Li Y, Weidolf L, Page K, Wilson I, Swallow S, Middleton B, Stahl S, Foster AJ, Dolgos H, Weaver R, Kenna JG (2012) In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs
Diabetes 42:16781682 Kolligs F, Fehmann HC, Gke R, Gke B (1995) Reduction of the incretin effect in rats by the glucagon-like peptide receptor antagonist exendin (939) amide
Weight reduction most likely played a large role in heart health, but researchers are also finding convincing early evidence that GLP-1and the drugsmay reduce inflammation when bound to receptors
Certain health histories may preclude the use of tirzepatide
Is tirzepatide approved for everyone who wants to lose weight